AMBEV S.A. — Director's Dealing 2017

Nov 13, 2017

6-K 1 ambevsacvm358oct2017_6k1.htm FORM 6-K ambevsacvm358oct2017_6k1.htm - Generated by SEC Publisher for SEC Filing

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of November, 2017

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F X Form 40-F _

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _ No X_

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In October 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.					CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives	Securities Characteristics (2)			Quantity	%
					Same Class and Type		Total
Shares	Common			9,798,254	0.0623		0.0623
Transac tions in the month
Securities / Derivatives	Securities Characteristics (2)	Intermediary	Operation	Day	Quantity	Price	Volume (R$) (3)
Shares	Common	Direct with the Company	Conversion in ADRs	04	49,960	0.00	0.00
			Total Conversion ADRs (Out)		49,960		0.00
Shares	Common	Direct with the Company	Exerc Options	04	30,125	9.35960	281,957.95
Shares	Common	Direct with the Company	Exerc Options	06	59,750	1.29648	77,464.68
Shares	Common	Direct with the Company	Exerc Options	09	38,080	11.97200	455,893.76
			Total Sell		127,955		815,316.39
Shares	Common	Direct with the Company	Plan of Shares Acquisition	04	13,300	21.20	281,960.00
Shares	Common	Direct with the Company	Plan of Shares Acquisition	09	21,638	21.07	455,912.66
			Total Buy		34,938		737,872.66
Final Balance
Securities / Derivatives	Securities Characteristics (2)			Quantity	%
					Same Class and Type		Total
Shares	Common			9,655,277	0.0614		0.0614

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price .

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In October 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.					CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives	Securities Characteristics (2)			Quantity	%
					Same Class and Type		Total
ADR (*)	Common			0	0.0000		0.0000
Transac tions in the month
Securities / Derivatives	Securities Characteristics (2)	Intermediary	Operation	Day	Quantity	Price USD	Volume (USD) (3)
ADR (*)	Common	Direct with the Company	Conversion in ADRs	04	49,960	0.00	0.00
			Total Conversion ADRs (In)		49,960		0.00
ADR (*)	Common	Direct with the Company	Plan of Shares Acquisition	04	43,865	6.68	293,023.27
			Total Buy		43,865		293,023.27
ADR (*)	Common	Direct with the Company	Exerc Options	04	68,875	2.8628	197,175.35
ADR (*)	Common	Direct with the Company	Exerc Options	04	24,950	3.8416	95,847.92
			Total Sell		93,825		293,023.27
Final Balance
Securities / Derivatives	Securities Characteristics (2)			Quantity	%
					Same Class and Type		Total
ADR (*)	Common			0	0.0000		0.0000

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price .

(*) Each ADR is equivalent to 1 (one) share.

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In October 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Subsidiary Name: Ambev Luxembourg S.À.R.L.
Qualification: Position – Total Return Swap
Transac tions in the month
Securities / Derivatives	Securities Characteristics (1)	Intermediary	Operation	Day	Quantity (**)	Price USD	Volume (USD) (2)
Swap	Swap referenced in Shares	N/A	Total Return Swap Conclusion	02 (*)	1,450,000	20.6420	29,930,900.00
Swap	Swap referenced in Shares	N/A	Total Return Swap Conclusion	30 (*)	379,900	20.8866	7,934,819.34
			Total operation		1,829,900		37,865,719.34

(1) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(2) Quantity multiplied by price .

(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

() The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.**

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 10, 2017

AMBEV S.A.
By:	/s/ Ricardo Rittes de Oliveira Silva
	Ricardo Rittes de Oliveira Silva Chief Financial and Investor Relations Officer